nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—COMT—breast cancer	0.214	0.745	CbGaD
Dopamine—L-DOPA—Melphalan—breast cancer	0.202	1	CrCrCtD
Dopamine—SLC22A3—Melphalan—breast cancer	0.0879	0.297	CbGbCtD
Dopamine—CYP2D6—breast cancer	0.0731	0.255	CbGaD
Dopamine—SLC22A3—Irinotecan—breast cancer	0.0297	0.1	CbGbCtD
Dopamine—CYP1A2—Anastrozole—breast cancer	0.0209	0.0705	CbGbCtD
Dopamine—CYP1A2—Toremifene—breast cancer	0.0191	0.0645	CbGbCtD
Dopamine—CYP2C9—Anastrozole—breast cancer	0.0188	0.0635	CbGbCtD
Dopamine—SLC22A2—Vinblastine—breast cancer	0.0157	0.0528	CbGbCtD
Dopamine—CYP2C19—Lapatinib—breast cancer	0.0151	0.051	CbGbCtD
Dopamine—CYP2C9—Idarubicin—breast cancer	0.0143	0.0481	CbGbCtD
Dopamine—CYP2D6—Idarubicin—breast cancer	0.013	0.044	CbGbCtD
Dopamine—CYP2C9—Capecitabine—breast cancer	0.00782	0.0264	CbGbCtD
Dopamine—CYP2C19—Tamoxifen—breast cancer	0.00756	0.0255	CbGbCtD
Dopamine—CYP1A2—Tamoxifen—breast cancer	0.00698	0.0236	CbGbCtD
Dopamine—CYP2D6—Vinorelbine—breast cancer	0.00637	0.0215	CbGbCtD
Dopamine—CYP2C9—Tamoxifen—breast cancer	0.00629	0.0212	CbGbCtD
Dopamine—CYP2D6—Tamoxifen—breast cancer	0.00575	0.0194	CbGbCtD
Dopamine—CYP1A2—Fluorouracil—breast cancer	0.00514	0.0174	CbGbCtD
Dopamine—CYP2C9—Paclitaxel—breast cancer	0.0049	0.0165	CbGbCtD
Dopamine—CYP2C9—Fluorouracil—breast cancer	0.00463	0.0156	CbGbCtD
Dopamine—CYP2D6—Vinblastine—breast cancer	0.00393	0.0133	CbGbCtD
Dopamine—Piloerection—Irinotecan—breast cancer	0.00296	0.0452	CcSEcCtD
Dopamine—CYP2D6—Doxorubicin—breast cancer	0.00241	0.00814	CbGbCtD
Dopamine—Gangrene—Gemcitabine—breast cancer	0.00229	0.0349	CcSEcCtD
Dopamine—Extravasation—Carboplatin—breast cancer	0.00182	0.0278	CcSEcCtD
Dopamine—Necrosis—Idarubicin—breast cancer	0.00129	0.0196	CcSEcCtD
Dopamine—Extravasation—Idarubicin—breast cancer	0.00116	0.0176	CcSEcCtD
Dopamine—Masoprocol—IGF1R—breast cancer	0.00102	0.346	CrCbGaD
Dopamine—Menorrhagia—Goserelin—breast cancer	0.000941	0.0143	CcSEcCtD
Dopamine—Extravasation—Vinblastine—breast cancer	0.00086	0.0131	CcSEcCtD
Dopamine—Angina pectoris—Toremifene—breast cancer	0.000832	0.0127	CcSEcCtD
Dopamine—Extravasation—Melphalan—breast cancer	0.000818	0.0125	CcSEcCtD
Dopamine—Extravasation—Goserelin—breast cancer	0.000798	0.0122	CcSEcCtD
Dopamine—Necrosis—Vinorelbine—breast cancer	0.000794	0.0121	CcSEcCtD
Dopamine—Anxiety—Fluoxymesterone—breast cancer	0.000784	0.0119	CcSEcCtD
Dopamine—Atrial fibrillation—Idarubicin—breast cancer	0.000774	0.0118	CcSEcCtD
Dopamine—COMT—nipple—breast cancer	0.000736	0.0254	CbGeAlD
Dopamine—Angina pectoris—Exemestane—breast cancer	0.000733	0.0112	CcSEcCtD
Dopamine—Extravasation—Vinorelbine—breast cancer	0.000715	0.0109	CcSEcCtD
Dopamine—DBH—female reproductive system—breast cancer	0.000697	0.024	CbGeAlD
Dopamine—Menorrhagia—Mitoxantrone—breast cancer	0.000695	0.0106	CcSEcCtD
Dopamine—Angina pectoris—Ixabepilone—breast cancer	0.000691	0.0105	CcSEcCtD
Dopamine—Extravasation—Thiotepa—breast cancer	0.000682	0.0104	CcSEcCtD
Dopamine—DBH—adrenal gland—breast cancer	0.00068	0.0235	CbGeAlD
Dopamine—DBH—bone marrow—breast cancer	0.000658	0.0227	CbGeAlD
Dopamine—Necrosis—Mitoxantrone—breast cancer	0.000655	0.00998	CcSEcCtD
Dopamine—Angina pectoris—Anastrozole—breast cancer	0.000651	0.00991	CcSEcCtD
Dopamine—Angina pectoris—Letrozole—breast cancer	0.000651	0.00991	CcSEcCtD
Dopamine—Necrosis—Fluorouracil—breast cancer	0.000627	0.00956	CcSEcCtD
Dopamine—SLC22A3—nipple—breast cancer	0.000619	0.0214	CbGeAlD
Dopamine—DBH—endocrine gland—breast cancer	0.00059	0.0203	CbGeAlD
Dopamine—Extravasation—Irinotecan—breast cancer	0.000589	0.00898	CcSEcCtD
Dopamine—Extravasation—Mitoxantrone—breast cancer	0.000589	0.00898	CcSEcCtD
Dopamine—Palpitations—Lapatinib—breast cancer	0.00058	0.00883	CcSEcCtD
Dopamine—Extravasation—Gemcitabine—breast cancer	0.000574	0.00874	CcSEcCtD
Dopamine—MAOB—nipple—breast cancer	0.000573	0.0198	CbGeAlD
Dopamine—Extravasation—Fluorouracil—breast cancer	0.000564	0.0086	CcSEcCtD
Dopamine—Atrial fibrillation—Melphalan—breast cancer	0.000547	0.00833	CcSEcCtD
Dopamine—SLC22A5—mammary gland—breast cancer	0.000544	0.0188	CbGeAlD
Dopamine—DRD5—female reproductive system—breast cancer	0.000536	0.0185	CbGeAlD
Dopamine—Necrosis—Paclitaxel—breast cancer	0.000534	0.00814	CcSEcCtD
Dopamine—Anxiety—Fulvestrant—breast cancer	0.000512	0.0078	CcSEcCtD
Dopamine—SLC22A3—embryo—breast cancer	0.000511	0.0176	CbGeAlD
Dopamine—Extrasystoles—Paclitaxel—breast cancer	0.000498	0.00759	CcSEcCtD
Dopamine—MAOA—nipple—breast cancer	0.000489	0.0169	CbGeAlD
Dopamine—DRD5—female gonad—breast cancer	0.000487	0.0168	CbGeAlD
Dopamine—Azotaemia—Methotrexate—breast cancer	0.000481	0.00732	CcSEcCtD
Dopamine—Extravasation—Paclitaxel—breast cancer	0.000481	0.00732	CcSEcCtD
Dopamine—Dyspnoea—Lapatinib—breast cancer	0.000477	0.00727	CcSEcCtD
Dopamine—MAOB—embryo—breast cancer	0.000473	0.0163	CbGeAlD
Dopamine—Headache—Fluoxymesterone—breast cancer	0.000472	0.0072	CcSEcCtD
Dopamine—COMT—skin of body—breast cancer	0.000472	0.0163	CbGeAlD
Dopamine—CYP2C9—mammary gland—breast cancer	0.000468	0.0161	CbGeAlD
Dopamine—Angina pectoris—Vinblastine—breast cancer	0.000459	0.00698	CcSEcCtD
Dopamine—Methyldopa—COMT—breast cancer	0.000455	0.155	CrCbGaD
Dopamine—Dobutamine—COMT—breast cancer	0.000455	0.155	CrCbGaD
Dopamine—DRD5—endocrine gland—breast cancer	0.000453	0.0156	CbGeAlD
Dopamine—Necrosis—Docetaxel—breast cancer	0.000453	0.0069	CcSEcCtD
Dopamine—Hypertension—Exemestane—breast cancer	0.000452	0.00689	CcSEcCtD
Dopamine—SLC22A5—nipple—breast cancer	0.00045	0.0155	CbGeAlD
Dopamine—Nausea—Fluoxymesterone—breast cancer	0.000448	0.00682	CcSEcCtD
Dopamine—Angina pectoris—Tamoxifen—breast cancer	0.000445	0.00678	CcSEcCtD
Dopamine—COMT—endometrium—breast cancer	0.000445	0.0153	CbGeAlD
Dopamine—Anxiety—Exemestane—breast cancer	0.000445	0.00677	CcSEcCtD
Dopamine—Dyspnoea—Fulvestrant—breast cancer	0.000439	0.00669	CcSEcCtD
Dopamine—Dyspnoea—Toremifene—breast cancer	0.000433	0.0066	CcSEcCtD
Dopamine—Angina pectoris—Goserelin—breast cancer	0.000425	0.00648	CcSEcCtD
Dopamine—Palpitations—Letrozole—breast cancer	0.000411	0.00627	CcSEcCtD
Dopamine—COMT—uterus—breast cancer	0.00041	0.0141	CbGeAlD
Dopamine—Extrasystoles—Capecitabine—breast cancer	0.000409	0.00623	CcSEcCtD
Dopamine—CYP1A2—nipple—breast cancer	0.000408	0.0141	CbGeAlD
Dopamine—DBH—lymph node—breast cancer	0.000408	0.0141	CbGeAlD
Dopamine—Extravasation—Docetaxel—breast cancer	0.000407	0.00621	CcSEcCtD
Dopamine—MAOA—embryo—breast cancer	0.000403	0.0139	CbGeAlD
Dopamine—COMT—pituitary gland—breast cancer	0.000402	0.0139	CbGeAlD
Dopamine—Hypertension—Anastrozole—breast cancer	0.000402	0.00612	CcSEcCtD
Dopamine—Hypertension—Letrozole—breast cancer	0.000402	0.00612	CcSEcCtD
Dopamine—COMT—adipose tissue—breast cancer	0.000401	0.0138	CbGeAlD
Dopamine—Anxiety—Letrozole—breast cancer	0.000395	0.00602	CcSEcCtD
Dopamine—Anxiety—Anastrozole—breast cancer	0.000395	0.00602	CcSEcCtD
Dopamine—Dyspnoea—Exemestane—breast cancer	0.000381	0.00581	CcSEcCtD
Dopamine—Angina pectoris—Vinorelbine—breast cancer	0.000381	0.0058	CcSEcCtD
Dopamine—SLC22A3—endometrium—breast cancer	0.000374	0.0129	CbGeAlD
Dopamine—Tachycardia—Letrozole—breast cancer	0.000371	0.00565	CcSEcCtD
Dopamine—COMT—female reproductive system—breast cancer	0.000368	0.0127	CbGeAlD
Dopamine—Cyanosis—Methotrexate—breast cancer	0.000362	0.00551	CcSEcCtD
Dopamine—Dyspnoea—Ixabepilone—breast cancer	0.00036	0.00548	CcSEcCtD
Dopamine—COMT—adrenal gland—breast cancer	0.000359	0.0124	CbGeAlD
Dopamine—SLC22A1—adipose tissue—breast cancer	0.000353	0.0122	CbGeAlD
Dopamine—COMT—bone marrow—breast cancer	0.000348	0.012	CbGeAlD
Dopamine—MAOB—endometrium—breast cancer	0.000346	0.0119	CbGeAlD
Dopamine—HTR7—epithelium—breast cancer	0.000344	0.0119	CbGeAlD
Dopamine—Vomiting—Lapatinib—breast cancer	0.00034	0.00518	CcSEcCtD
Dopamine—ADRB1—adipose tissue—breast cancer	0.000339	0.0117	CbGeAlD
Dopamine—Dyspnoea—Anastrozole—breast cancer	0.000339	0.00516	CcSEcCtD
Dopamine—Dyspnoea—Letrozole—breast cancer	0.000339	0.00516	CcSEcCtD
Dopamine—SLC22A3—adipose tissue—breast cancer	0.000337	0.0116	CbGeAlD
Dopamine—Headache—Lapatinib—breast cancer	0.000335	0.00511	CcSEcCtD
Dopamine—COMT—female gonad—breast cancer	0.000335	0.0116	CbGeAlD
Dopamine—Necrosis—Methotrexate—breast cancer	0.000326	0.00497	CcSEcCtD
Dopamine—Ventricular arrhythmia—Epirubicin—breast cancer	0.000324	0.00493	CcSEcCtD
Dopamine—Masoprocol—CYP19A1—breast cancer	0.000322	0.11	CrCbGaD
Dopamine—Atrial fibrillation—Paclitaxel—breast cancer	0.000321	0.00489	CcSEcCtD
Dopamine—MAOB—uterus—breast cancer	0.000319	0.011	CbGeAlD
Dopamine—Nausea—Lapatinib—breast cancer	0.000318	0.00484	CcSEcCtD
Dopamine—Angina pectoris—Irinotecan—breast cancer	0.000314	0.00479	CcSEcCtD
Dopamine—Vomiting—Fulvestrant—breast cancer	0.000313	0.00477	CcSEcCtD
Dopamine—MAOB—pituitary gland—breast cancer	0.000313	0.0108	CbGeAlD
Dopamine—ADRB1—female reproductive system—breast cancer	0.000312	0.0108	CbGeAlD
Dopamine—MAOB—adipose tissue—breast cancer	0.000312	0.0108	CbGeAlD
Dopamine—COMT—endocrine gland—breast cancer	0.000312	0.0108	CbGeAlD
Dopamine—SLC22A3—female reproductive system—breast cancer	0.00031	0.0107	CbGeAlD
Dopamine—Vomiting—Toremifene—breast cancer	0.000309	0.00471	CcSEcCtD
Dopamine—Headache—Fulvestrant—breast cancer	0.000308	0.0047	CcSEcCtD
Dopamine—Necrosis—Epirubicin—breast cancer	0.000305	0.00465	CcSEcCtD
Dopamine—Headache—Toremifene—breast cancer	0.000304	0.00464	CcSEcCtD
Dopamine—SLC22A3—adrenal gland—breast cancer	0.000302	0.0104	CbGeAlD
Dopamine—SLC6A4—female reproductive system—breast cancer	0.000301	0.0104	CbGeAlD
Dopamine—Angina pectoris—Fluorouracil—breast cancer	0.000301	0.00458	CcSEcCtD
Dopamine—Ventricular arrhythmia—Doxorubicin—breast cancer	0.0003	0.00457	CcSEcCtD
Dopamine—MAOA—endometrium—breast cancer	0.000295	0.0102	CbGeAlD
Dopamine—Extravasation—Methotrexate—breast cancer	0.000294	0.00447	CcSEcCtD
Dopamine—Nausea—Fulvestrant—breast cancer	0.000292	0.00445	CcSEcCtD
Dopamine—Nausea—Toremifene—breast cancer	0.000289	0.0044	CcSEcCtD
Dopamine—SLC22A5—skin of body—breast cancer	0.000288	0.00995	CbGeAlD
Dopamine—MAOB—female reproductive system—breast cancer	0.000287	0.00989	CbGeAlD
Dopamine—Hypertension—Vinblastine—breast cancer	0.000283	0.00431	CcSEcCtD
Dopamine—Necrosis—Doxorubicin—breast cancer	0.000283	0.00431	CcSEcCtD
Dopamine—SLC22A3—female gonad—breast cancer	0.000282	0.00972	CbGeAlD
Dopamine—MAOB—adrenal gland—breast cancer	0.00028	0.00965	CbGeAlD
Dopamine—Hypertension—Tamoxifen—breast cancer	0.000275	0.00419	CcSEcCtD
Dopamine—Extravasation—Epirubicin—breast cancer	0.000275	0.00419	CcSEcCtD
Dopamine—SLC22A1—endocrine gland—breast cancer	0.000274	0.00946	CbGeAlD
Dopamine—Atrial fibrillation—Docetaxel—breast cancer	0.000272	0.00415	CcSEcCtD
Dopamine—MAOA—uterus—breast cancer	0.000272	0.00938	CbGeAlD
Dopamine—Vomiting—Exemestane—breast cancer	0.000272	0.00414	CcSEcCtD
Dopamine—SLC22A5—endometrium—breast cancer	0.000272	0.00938	CbGeAlD
Dopamine—Anxiety—Tamoxifen—breast cancer	0.00027	0.00412	CcSEcCtD
Dopamine—Palpitations—Goserelin—breast cancer	0.000269	0.0041	CcSEcCtD
Dopamine—Headache—Exemestane—breast cancer	0.000268	0.00408	CcSEcCtD
Dopamine—MAOA—pituitary gland—breast cancer	0.000267	0.00922	CbGeAlD
Dopamine—MAOA—adipose tissue—breast cancer	0.000266	0.00918	CbGeAlD
Dopamine—SLC6A2—female reproductive system—breast cancer	0.000265	0.00916	CbGeAlD
Dopamine—DRD2—pituitary gland—breast cancer	0.000264	0.00911	CbGeAlD
Dopamine—ADRB1—endocrine gland—breast cancer	0.000264	0.00911	CbGeAlD
Dopamine—Atrial fibrillation—Capecitabine—breast cancer	0.000264	0.00402	CcSEcCtD
Dopamine—Bradycardia—Irinotecan—breast cancer	0.000263	0.004	CcSEcCtD
Dopamine—Bradycardia—Mitoxantrone—breast cancer	0.000263	0.004	CcSEcCtD
Dopamine—Hypertension—Goserelin—breast cancer	0.000263	0.004	CcSEcCtD
Dopamine—SLC22A3—endocrine gland—breast cancer	0.000262	0.00904	CbGeAlD
Dopamine—HTR1A—adrenal gland—breast cancer	0.000261	0.00901	CbGeAlD
Dopamine—MAOB—female gonad—breast cancer	0.000261	0.009	CbGeAlD
Dopamine—SLC6A2—adrenal gland—breast cancer	0.000259	0.00894	CbGeAlD
Dopamine—Anxiety—Goserelin—breast cancer	0.000258	0.00393	CcSEcCtD
Dopamine—Vomiting—Ixabepilone—breast cancer	0.000257	0.00391	CcSEcCtD
Dopamine—HTR7—female reproductive system—breast cancer	0.000256	0.00883	CbGeAlD
Dopamine—SLC6A4—endocrine gland—breast cancer	0.000255	0.0088	CbGeAlD
Dopamine—Extravasation—Doxorubicin—breast cancer	0.000254	0.00387	CcSEcCtD
Dopamine—Nausea—Exemestane—breast cancer	0.000254	0.00387	CcSEcCtD
Dopamine—Headache—Ixabepilone—breast cancer	0.000253	0.00385	CcSEcCtD
Dopamine—HTR7—adrenal gland—breast cancer	0.00025	0.00861	CbGeAlD
Dopamine—Tachycardia—Melphalan—breast cancer	0.000249	0.00379	CcSEcCtD
Dopamine—SLC22A5—pituitary gland—breast cancer	0.000246	0.00849	CbGeAlD
Dopamine—SLC22A5—adipose tissue—breast cancer	0.000245	0.00845	CbGeAlD
Dopamine—MAOA—female reproductive system—breast cancer	0.000244	0.00844	CbGeAlD
Dopamine—MAOB—endocrine gland—breast cancer	0.000243	0.00837	CbGeAlD
Dopamine—Tachycardia—Goserelin—breast cancer	0.000242	0.00369	CcSEcCtD
Dopamine—Vomiting—Anastrozole—breast cancer	0.000242	0.00368	CcSEcCtD
Dopamine—Vomiting—Letrozole—breast cancer	0.000242	0.00368	CcSEcCtD
Dopamine—Palpitations—Vinorelbine—breast cancer	0.000241	0.00367	CcSEcCtD
Dopamine—Nausea—Ixabepilone—breast cancer	0.00024	0.00365	CcSEcCtD
Dopamine—MAOA—adrenal gland—breast cancer	0.000239	0.00823	CbGeAlD
Dopamine—Headache—Anastrozole—breast cancer	0.000238	0.00363	CcSEcCtD
Dopamine—Headache—Letrozole—breast cancer	0.000238	0.00363	CcSEcCtD
Dopamine—Hypertension—Vinorelbine—breast cancer	0.000235	0.00358	CcSEcCtD
Dopamine—Dyspnoea—Tamoxifen—breast cancer	0.000232	0.00353	CcSEcCtD
Dopamine—Vomiting—Idarubicin—breast cancer	0.000229	0.00349	CcSEcCtD
Dopamine—Vomiting—Raloxifene—breast cancer	0.000229	0.00349	CcSEcCtD
Dopamine—Dyspnoea—Melphalan—breast cancer	0.000227	0.00346	CcSEcCtD
Dopamine—HTR1A—endocrine gland—breast cancer	0.000226	0.00781	CbGeAlD
Dopamine—Headache—Idarubicin—breast cancer	0.000226	0.00344	CcSEcCtD
Dopamine—Headache—Raloxifene—breast cancer	0.000226	0.00344	CcSEcCtD
Dopamine—Nausea—Anastrozole—breast cancer	0.000226	0.00344	CcSEcCtD
Dopamine—Nausea—Letrozole—breast cancer	0.000226	0.00344	CcSEcCtD
Dopamine—SLC22A5—female reproductive system—breast cancer	0.000225	0.00777	CbGeAlD
Dopamine—Hypertension—Thiotepa—breast cancer	0.000225	0.00342	CcSEcCtD
Dopamine—SLC6A2—endocrine gland—breast cancer	0.000225	0.00775	CbGeAlD
Dopamine—MAOA—female gonad—breast cancer	0.000222	0.00768	CbGeAlD
Dopamine—Dyspnoea—Goserelin—breast cancer	0.000221	0.00337	CcSEcCtD
Dopamine—Anxiety—Thiotepa—breast cancer	0.000221	0.00336	CcSEcCtD
Dopamine—SLC22A5—adrenal gland—breast cancer	0.00022	0.00758	CbGeAlD
Dopamine—Angina pectoris—Docetaxel—breast cancer	0.000217	0.00331	CcSEcCtD
Dopamine—Tachycardia—Vinorelbine—breast cancer	0.000217	0.00331	CcSEcCtD
Dopamine—HTR7—endocrine gland—breast cancer	0.000216	0.00747	CbGeAlD
Dopamine—COMT—lymph node—breast cancer	0.000215	0.00743	CbGeAlD
Dopamine—Bradycardia—Paclitaxel—breast cancer	0.000214	0.00327	CcSEcCtD
Dopamine—Nausea—Raloxifene—breast cancer	0.000214	0.00326	CcSEcCtD
Dopamine—Nausea—Idarubicin—breast cancer	0.000214	0.00326	CcSEcCtD
Dopamine—CYP2C19—endocrine gland—breast cancer	0.000211	0.00729	CbGeAlD
Dopamine—Angina pectoris—Capecitabine—breast cancer	0.00021	0.0032	CcSEcCtD
Dopamine—Tachycardia—Thiotepa—breast cancer	0.000207	0.00316	CcSEcCtD
Dopamine—MAOA—endocrine gland—breast cancer	0.000207	0.00714	CbGeAlD
Dopamine—SLC22A5—female gonad—breast cancer	0.000205	0.00707	CbGeAlD
Dopamine—DRD2—endocrine gland—breast cancer	0.000205	0.00706	CbGeAlD
Dopamine—Dyspnoea—Vinorelbine—breast cancer	0.000198	0.00302	CcSEcCtD
Dopamine—Hypertension—Irinotecan—breast cancer	0.000194	0.00296	CcSEcCtD
Dopamine—Hypertension—Mitoxantrone—breast cancer	0.000194	0.00296	CcSEcCtD
Dopamine—CYP2C9—female reproductive system—breast cancer	0.000194	0.00668	CbGeAlD
Dopamine—Anxiety—Mitoxantrone—breast cancer	0.000191	0.0029	CcSEcCtD
Dopamine—Hypertension—Gemcitabine—breast cancer	0.000189	0.00288	CcSEcCtD
Dopamine—Mesalazine—PTGS1—breast cancer	0.000189	0.0643	CrCbGaD
Dopamine—Vomiting—Chlorambucil—breast cancer	0.000186	0.00283	CcSEcCtD
Dopamine—SLC22A3—lymph node—breast cancer	0.000181	0.00625	CbGeAlD
Dopamine—Tachycardia—Mitoxantrone—breast cancer	0.000179	0.00273	CcSEcCtD
Dopamine—Bradycardia—Capecitabine—breast cancer	0.000176	0.00268	CcSEcCtD
Dopamine—Nausea—Chlorambucil—breast cancer	0.000174	0.00264	CcSEcCtD
Dopamine—CYP1A2—endocrine gland—breast cancer	0.000173	0.00596	CbGeAlD
Dopamine—Tachycardia—Fluorouracil—breast cancer	0.000171	0.00261	CcSEcCtD
Dopamine—Vomiting—Vinblastine—breast cancer	0.00017	0.00259	CcSEcCtD
Dopamine—Headache—Vinblastine—breast cancer	0.000168	0.00255	CcSEcCtD
Dopamine—MAOB—lymph node—breast cancer	0.000168	0.00578	CbGeAlD
Dopamine—Vomiting—Tamoxifen—breast cancer	0.000165	0.00252	CcSEcCtD
Dopamine—CYP2C9—endocrine gland—breast cancer	0.000164	0.00565	CbGeAlD
Dopamine—Dyspnoea—Irinotecan—breast cancer	0.000164	0.00249	CcSEcCtD
Dopamine—Dyspnoea—Mitoxantrone—breast cancer	0.000164	0.00249	CcSEcCtD
Dopamine—Headache—Tamoxifen—breast cancer	0.000163	0.00248	CcSEcCtD
Dopamine—Palpitations—Paclitaxel—breast cancer	0.000162	0.00247	CcSEcCtD
Dopamine—Vomiting—Melphalan—breast cancer	0.000162	0.00247	CcSEcCtD
Dopamine—Dyspnoea—Gemcitabine—breast cancer	0.000159	0.00243	CcSEcCtD
Dopamine—Nausea—Vinblastine—breast cancer	0.000159	0.00242	CcSEcCtD
Dopamine—Hypertension—Paclitaxel—breast cancer	0.000158	0.00241	CcSEcCtD
Dopamine—Vomiting—Goserelin—breast cancer	0.000158	0.00241	CcSEcCtD
Dopamine—Dyspnoea—Fluorouracil—breast cancer	0.000157	0.00239	CcSEcCtD
Dopamine—Headache—Goserelin—breast cancer	0.000156	0.00237	CcSEcCtD
Dopamine—Anxiety—Paclitaxel—breast cancer	0.000156	0.00237	CcSEcCtD
Dopamine—SLC6A2—lymph node—breast cancer	0.000155	0.00536	CbGeAlD
Dopamine—Nausea—Tamoxifen—breast cancer	0.000154	0.00235	CcSEcCtD
Dopamine—Nausea—Melphalan—breast cancer	0.000151	0.0023	CcSEcCtD
Dopamine—Nausea—Goserelin—breast cancer	0.000148	0.00225	CcSEcCtD
Dopamine—Angina pectoris—Epirubicin—breast cancer	0.000147	0.00223	CcSEcCtD
Dopamine—Tachycardia—Paclitaxel—breast cancer	0.000146	0.00222	CcSEcCtD
Dopamine—CYP2D6—female reproductive system—breast cancer	0.000145	0.00501	CbGeAlD
Dopamine—MAOA—lymph node—breast cancer	0.000143	0.00494	CbGeAlD
Dopamine—Vomiting—Vinorelbine—breast cancer	0.000141	0.00215	CcSEcCtD
Dopamine—Headache—Vinorelbine—breast cancer	0.000139	0.00212	CcSEcCtD
Dopamine—Palpitations—Docetaxel—breast cancer	0.000137	0.00209	CcSEcCtD
Dopamine—Angina pectoris—Doxorubicin—breast cancer	0.000136	0.00207	CcSEcCtD
Dopamine—Vomiting—Thiotepa—breast cancer	0.000135	0.00206	CcSEcCtD
Dopamine—Hypertension—Docetaxel—breast cancer	0.000134	0.00204	CcSEcCtD
Dopamine—Dyspnoea—Paclitaxel—breast cancer	0.000133	0.00203	CcSEcCtD
Dopamine—Headache—Thiotepa—breast cancer	0.000133	0.00203	CcSEcCtD
Dopamine—Palpitations—Capecitabine—breast cancer	0.000133	0.00203	CcSEcCtD
Dopamine—CYP2D6—female gonad—breast cancer	0.000132	0.00456	CbGeAlD
Dopamine—Nausea—Vinorelbine—breast cancer	0.000132	0.00201	CcSEcCtD
Dopamine—SLC22A5—lymph node—breast cancer	0.000132	0.00455	CbGeAlD
Dopamine—Epinephrine—TNF—breast cancer	0.000131	0.0445	CrCbGaD
Dopamine—Hypertension—Capecitabine—breast cancer	0.00013	0.00198	CcSEcCtD
Dopamine—Anxiety—Capecitabine—breast cancer	0.000128	0.00194	CcSEcCtD
Dopamine—Nausea—Thiotepa—breast cancer	0.000126	0.00192	CcSEcCtD
Dopamine—Tachycardia—Docetaxel—breast cancer	0.000124	0.00189	CcSEcCtD
Dopamine—CYP2D6—endocrine gland—breast cancer	0.000123	0.00424	CbGeAlD
Dopamine—Bradycardia—Epirubicin—breast cancer	0.000123	0.00187	CcSEcCtD
Dopamine—Tachycardia—Capecitabine—breast cancer	0.00012	0.00183	CcSEcCtD
Dopamine—Isoprenaline—CYP1A1—breast cancer	0.000118	0.0403	CrCbGaD
Dopamine—Vomiting—Mitoxantrone—breast cancer	0.000117	0.00178	CcSEcCtD
Dopamine—Vomiting—Irinotecan—breast cancer	0.000117	0.00178	CcSEcCtD
Dopamine—Headache—Mitoxantrone—breast cancer	0.000115	0.00175	CcSEcCtD
Dopamine—Headache—Irinotecan—breast cancer	0.000115	0.00175	CcSEcCtD
Dopamine—Vomiting—Gemcitabine—breast cancer	0.000114	0.00173	CcSEcCtD
Dopamine—Bradycardia—Doxorubicin—breast cancer	0.000113	0.00173	CcSEcCtD
Dopamine—Dyspnoea—Docetaxel—breast cancer	0.000113	0.00172	CcSEcCtD
Dopamine—Headache—Gemcitabine—breast cancer	0.000112	0.00171	CcSEcCtD
Dopamine—Vomiting—Fluorouracil—breast cancer	0.000112	0.0017	CcSEcCtD
Dopamine—Headache—Fluorouracil—breast cancer	0.00011	0.00168	CcSEcCtD
Dopamine—Dyspnoea—Capecitabine—breast cancer	0.000109	0.00167	CcSEcCtD
Dopamine—Nausea—Irinotecan—breast cancer	0.000109	0.00166	CcSEcCtD
Dopamine—Nausea—Mitoxantrone—breast cancer	0.000109	0.00166	CcSEcCtD
Dopamine—Mesalazine—PTGS2—breast cancer	0.000108	0.0367	CrCbGaD
Dopamine—Nausea—Gemcitabine—breast cancer	0.000106	0.00162	CcSEcCtD
Dopamine—Nausea—Fluorouracil—breast cancer	0.000104	0.00159	CcSEcCtD
Dopamine—Vomiting—Paclitaxel—breast cancer	9.51e-05	0.00145	CcSEcCtD
Dopamine—Headache—Paclitaxel—breast cancer	9.37e-05	0.00143	CcSEcCtD
Dopamine—Palpitations—Epirubicin—breast cancer	9.26e-05	0.00141	CcSEcCtD
Dopamine—Hypertension—Epirubicin—breast cancer	9.05e-05	0.00138	CcSEcCtD
Dopamine—Anxiety—Epirubicin—breast cancer	8.89e-05	0.00135	CcSEcCtD
Dopamine—Nausea—Paclitaxel—breast cancer	8.89e-05	0.00135	CcSEcCtD
Dopamine—Palpitations—Doxorubicin—breast cancer	8.57e-05	0.00131	CcSEcCtD
Dopamine—Hypertension—Doxorubicin—breast cancer	8.37e-05	0.00128	CcSEcCtD
Dopamine—Tachycardia—Epirubicin—breast cancer	8.35e-05	0.00127	CcSEcCtD
Dopamine—Anxiety—Doxorubicin—breast cancer	8.23e-05	0.00125	CcSEcCtD
Dopamine—L-DOPA—CYP2D6—breast cancer	8.16e-05	0.0278	CrCbGaD
Dopamine—Dyspnoea—Methotrexate—breast cancer	8.15e-05	0.00124	CcSEcCtD
Dopamine—Vomiting—Docetaxel—breast cancer	8.06e-05	0.00123	CcSEcCtD
Dopamine—Headache—Docetaxel—breast cancer	7.95e-05	0.00121	CcSEcCtD
Dopamine—Vomiting—Capecitabine—breast cancer	7.81e-05	0.00119	CcSEcCtD
Dopamine—Tachycardia—Doxorubicin—breast cancer	7.72e-05	0.00118	CcSEcCtD
Dopamine—Headache—Capecitabine—breast cancer	7.69e-05	0.00117	CcSEcCtD
Dopamine—Dyspnoea—Epirubicin—breast cancer	7.63e-05	0.00116	CcSEcCtD
Dopamine—Nausea—Docetaxel—breast cancer	7.53e-05	0.00115	CcSEcCtD
Dopamine—Nausea—Capecitabine—breast cancer	7.29e-05	0.00111	CcSEcCtD
Dopamine—Dyspnoea—Doxorubicin—breast cancer	7.06e-05	0.00107	CcSEcCtD
Dopamine—Epinephrine—CYP3A4—breast cancer	6.35e-05	0.0216	CrCbGaD
Dopamine—Vomiting—Methotrexate—breast cancer	5.81e-05	0.000885	CcSEcCtD
Dopamine—Headache—Methotrexate—breast cancer	5.73e-05	0.000872	CcSEcCtD
Dopamine—Vomiting—Epirubicin—breast cancer	5.44e-05	0.000828	CcSEcCtD
Dopamine—Nausea—Methotrexate—breast cancer	5.43e-05	0.000827	CcSEcCtD
Dopamine—Headache—Epirubicin—breast cancer	5.36e-05	0.000816	CcSEcCtD
Dopamine—Nausea—Epirubicin—breast cancer	5.08e-05	0.000774	CcSEcCtD
Dopamine—Vomiting—Doxorubicin—breast cancer	5.03e-05	0.000767	CcSEcCtD
Dopamine—Headache—Doxorubicin—breast cancer	4.96e-05	0.000755	CcSEcCtD
Dopamine—Nausea—Doxorubicin—breast cancer	4.7e-05	0.000716	CcSEcCtD
Dopamine—ADRB1—Signaling Pathways—MTOR—breast cancer	1.38e-06	1.18e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—breast cancer	1.38e-06	1.18e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—STAT3—breast cancer	1.38e-06	1.18e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCND1—breast cancer	1.38e-06	1.18e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—JUN—breast cancer	1.37e-06	1.18e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SRC—breast cancer	1.37e-06	1.17e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MTHFR—breast cancer	1.37e-06	1.17e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—breast cancer	1.37e-06	1.17e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	1.37e-06	1.17e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CTNNB1—breast cancer	1.36e-06	1.17e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GPX1—breast cancer	1.36e-06	1.17e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTEN—breast cancer	1.36e-06	1.16e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MDM2—breast cancer	1.36e-06	1.16e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCND1—breast cancer	1.36e-06	1.16e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—JUN—breast cancer	1.36e-06	1.16e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RAF1—breast cancer	1.36e-06	1.16e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GPX1—breast cancer	1.35e-06	1.16e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CYP1A1—breast cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RELA—breast cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CTNNB1—breast cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ERBB2—breast cancer	1.34e-06	1.15e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ERCC2—breast cancer	1.34e-06	1.15e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CYP1A1—breast cancer	1.34e-06	1.14e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MMP9—breast cancer	1.34e-06	1.14e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—breast cancer	1.33e-06	1.14e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CD—breast cancer	1.33e-06	1.14e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDKN1A—breast cancer	1.33e-06	1.14e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.33e-06	1.14e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PTEN—breast cancer	1.33e-06	1.14e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CXCL8—breast cancer	1.33e-06	1.14e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ERCC2—breast cancer	1.33e-06	1.14e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CB—breast cancer	1.32e-06	1.13e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MTOR—breast cancer	1.32e-06	1.13e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—STAT3—breast cancer	1.32e-06	1.13e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HRAS—breast cancer	1.32e-06	1.13e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	1.32e-06	1.13e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MMP9—breast cancer	1.32e-06	1.13e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—COMT—breast cancer	1.32e-06	1.13e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MAPK3—breast cancer	1.32e-06	1.13e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SERPINE1—breast cancer	1.32e-06	1.13e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN1A—breast cancer	1.31e-06	1.12e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTP1—breast cancer	1.31e-06	1.12e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PTEN—breast cancer	1.31e-06	1.12e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HRAS—breast cancer	1.31e-06	1.12e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—KRAS—breast cancer	1.3e-06	1.12e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAPK8—breast cancer	1.3e-06	1.11e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1B—breast cancer	1.3e-06	1.11e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—AKT1—breast cancer	1.3e-06	1.11e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—HMOX1—breast cancer	1.3e-06	1.11e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ITPR1—breast cancer	1.29e-06	1.1e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—AKT1—breast cancer	1.28e-06	1.1e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAPK8—breast cancer	1.28e-06	1.1e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—breast cancer	1.28e-06	1.1e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—AKT1—breast cancer	1.28e-06	1.09e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TGFB1—breast cancer	1.28e-06	1.09e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP3—breast cancer	1.27e-06	1.09e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CXCL8—breast cancer	1.27e-06	1.09e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL2—breast cancer	1.27e-06	1.09e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTEN—breast cancer	1.27e-06	1.08e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—breast cancer	1.26e-06	1.08e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HRAS—breast cancer	1.26e-06	1.08e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CAV1—breast cancer	1.26e-06	1.08e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MAPK3—breast cancer	1.26e-06	1.08e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MTHFR—breast cancer	1.26e-06	1.08e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOS3—breast cancer	1.26e-06	1.08e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—breast cancer	1.25e-06	1.07e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—breast cancer	1.25e-06	1.07e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—AKT1—breast cancer	1.25e-06	1.07e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MTHFR—breast cancer	1.25e-06	1.07e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ABCB1—breast cancer	1.24e-06	1.06e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1B—breast cancer	1.24e-06	1.06e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCND1—breast cancer	1.24e-06	1.06e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—JUN—breast cancer	1.24e-06	1.06e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SRC—breast cancer	1.23e-06	1.05e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—AKT1—breast cancer	1.23e-06	1.05e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—breast cancer	1.23e-06	1.05e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CTNNB1—breast cancer	1.23e-06	1.05e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TGFB1—breast cancer	1.22e-06	1.05e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TYMS—breast cancer	1.22e-06	1.04e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP3—breast cancer	1.22e-06	1.04e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SRC—breast cancer	1.22e-06	1.04e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL2—breast cancer	1.22e-06	1.04e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—breast cancer	1.21e-06	1.03e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.21e-06	1.03e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTM1—breast cancer	1.21e-06	1.03e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NCOR1—breast cancer	1.21e-06	1.03e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.21e-06	1.03e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MMP9—breast cancer	1.2e-06	1.03e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—breast cancer	1.2e-06	1.03e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—breast cancer	1.2e-06	1.03e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PIK3CA—breast cancer	1.2e-06	1.03e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1A—breast cancer	1.2e-06	1.02e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PTEN—breast cancer	1.2e-06	1.02e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MDM2—breast cancer	1.19e-06	1.02e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RAF1—breast cancer	1.19e-06	1.02e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—STAT3—breast cancer	1.19e-06	1.02e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—breast cancer	1.19e-06	1.01e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KRAS—breast cancer	1.18e-06	1.01e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RELA—breast cancer	1.18e-06	1.01e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCND1—breast cancer	1.18e-06	1.01e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—JUN—breast cancer	1.18e-06	1.01e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ERBB2—breast cancer	1.18e-06	1.01e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—STAT3—breast cancer	1.17e-06	1e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CTNNB1—breast cancer	1.17e-06	1e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAPK8—breast cancer	1.17e-06	1e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—AKT1—breast cancer	1.17e-06	9.97e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CB—breast cancer	1.16e-06	9.93e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MTOR—breast cancer	1.16e-06	9.93e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CAV1—breast cancer	1.16e-06	9.93e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GPX1—breast cancer	1.16e-06	9.88e-06	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—AKT1—breast cancer	1.15e-06	9.86e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CAV1—breast cancer	1.15e-06	9.84e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MMP9—breast cancer	1.15e-06	9.83e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CG—breast cancer	1.15e-06	9.83e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1A—breast cancer	1.15e-06	9.8e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP1A1—breast cancer	1.14e-06	9.78e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTEN—breast cancer	1.14e-06	9.78e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAPK3—breast cancer	1.14e-06	9.71e-06	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PIK3CA—breast cancer	1.13e-06	9.7e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ERCC2—breast cancer	1.13e-06	9.7e-06	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KRAS—breast cancer	1.13e-06	9.7e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAPK3—breast cancer	1.12e-06	9.58e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAPK8—breast cancer	1.12e-06	9.56e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCL8—breast cancer	1.12e-06	9.55e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—AKT1—breast cancer	1.12e-06	9.54e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HRAS—breast cancer	1.11e-06	9.48e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SRC—breast cancer	1.11e-06	9.48e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—breast cancer	1.11e-06	9.45e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TGFB1—breast cancer	1.1e-06	9.43e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.1e-06	9.4e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—breast cancer	1.09e-06	9.32e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1B—breast cancer	1.09e-06	9.32e-06	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PIK3CA—breast cancer	1.09e-06	9.31e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TGFB1—breast cancer	1.09e-06	9.3e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—breast cancer	1.08e-06	9.24e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—breast cancer	1.08e-06	9.23e-06	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—AKT1—breast cancer	1.08e-06	9.22e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—STAT3—breast cancer	1.07e-06	9.14e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP3—breast cancer	1.07e-06	9.14e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL2—breast cancer	1.07e-06	9.12e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MTHFR—breast cancer	1.07e-06	9.12e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—breast cancer	1.07e-06	9.12e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—breast cancer	1.06e-06	9.08e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SRC—breast cancer	1.06e-06	9.07e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.06e-06	9.04e-06	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—breast cancer	1.05e-06	9e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CG—breast cancer	1.05e-06	8.97e-06	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PIK3CA—breast cancer	1.04e-06	8.91e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCND1—breast cancer	1.04e-06	8.89e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—JUN—breast cancer	1.04e-06	8.87e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—breast cancer	1.03e-06	8.83e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CTNNB1—breast cancer	1.03e-06	8.81e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—STAT3—breast cancer	1.02e-06	8.74e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.02e-06	8.73e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KRAS—breast cancer	1.02e-06	8.73e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CD—breast cancer	1.01e-06	8.64e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MMP9—breast cancer	1.01e-06	8.63e-06	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—breast cancer	1.01e-06	8.62e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KRAS—breast cancer	1.01e-06	8.61e-06	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HRAS—breast cancer	1.01e-06	8.61e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.01e-06	8.6e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTEN—breast cancer	1e-06	8.58e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ALB—breast cancer	9.98e-07	8.53e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—breast cancer	9.93e-07	8.49e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFB1—breast cancer	9.91e-07	8.47e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CAV1—breast cancer	9.84e-07	8.41e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAPK8—breast cancer	9.82e-07	8.4e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—AKT1—breast cancer	9.79e-07	8.37e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAPK3—breast cancer	9.77e-07	8.35e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—breast cancer	9.72e-07	8.31e-06	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HRAS—breast cancer	9.64e-07	8.24e-06	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—breast cancer	9.64e-07	8.24e-06	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3CA—breast cancer	9.6e-07	8.21e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NOS3—breast cancer	9.55e-07	8.16e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—breast cancer	9.5e-07	8.12e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFB1—breast cancer	9.48e-07	8.1e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.4e-07	8.04e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3CA—breast cancer	9.38e-07	8.02e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SRC—breast cancer	9.31e-07	7.96e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CD—breast cancer	9.3e-07	7.95e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—breast cancer	9.29e-07	7.95e-06	CbGpPWpGaD
Dopamine—MAOA—Metabolism—AKT1—breast cancer	9.27e-07	7.93e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3CA—breast cancer	9.26e-07	7.91e-06	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—breast cancer	9.23e-07	7.89e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CD—breast cancer	9.22e-07	7.88e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KRAS—breast cancer	9.18e-07	7.85e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ALB—breast cancer	9.18e-07	7.85e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ALB—breast cancer	9.1e-07	7.78e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—breast cancer	9.07e-07	7.76e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—breast cancer	9.07e-07	7.75e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STAT3—breast cancer	8.98e-07	7.68e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CG—breast cancer	8.96e-07	7.66e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—breast cancer	8.95e-07	7.66e-06	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CA—breast cancer	8.95e-07	7.65e-06	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—AKT1—breast cancer	8.89e-07	7.6e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CB—breast cancer	8.81e-07	7.53e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NOS3—breast cancer	8.78e-07	7.51e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KRAS—breast cancer	8.78e-07	7.51e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—breast cancer	8.73e-07	7.47e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NOS3—breast cancer	8.7e-07	7.44e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HRAS—breast cancer	8.68e-07	7.42e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAPK3—breast cancer	8.58e-07	7.33e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HRAS—breast cancer	8.56e-07	7.32e-06	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—AKT1—breast cancer	8.51e-07	7.28e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CA—breast cancer	8.43e-07	7.21e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—breast cancer	8.34e-07	7.13e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFB1—breast cancer	8.32e-07	7.12e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—breast cancer	8.31e-07	7.1e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—breast cancer	8.2e-07	7.01e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—breast cancer	8.16e-07	6.98e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—breast cancer	8.16e-07	6.98e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CB—breast cancer	8.1e-07	6.93e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	8.07e-07	6.9e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CB—breast cancer	8.03e-07	6.87e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—breast cancer	8.03e-07	6.87e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—breast cancer	7.96e-07	6.81e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CD—breast cancer	7.88e-07	6.74e-06	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—AKT1—breast cancer	7.84e-07	6.7e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—breast cancer	7.8e-07	6.67e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HRAS—breast cancer	7.8e-07	6.67e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALB—breast cancer	7.78e-07	6.65e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KRAS—breast cancer	7.71e-07	6.59e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—AKT1—breast cancer	7.66e-07	6.55e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTEN—breast cancer	7.61e-07	6.51e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—AKT1—breast cancer	7.56e-07	6.46e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—breast cancer	7.47e-07	6.39e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HRAS—breast cancer	7.46e-07	6.38e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NOS3—breast cancer	7.44e-07	6.36e-06	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—AKT1—breast cancer	7.31e-07	6.25e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—breast cancer	7.14e-07	6.11e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CA—breast cancer	7.08e-07	6.06e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTEN—breast cancer	7e-07	5.99e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTEN—breast cancer	6.94e-07	5.94e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT1—breast cancer	6.89e-07	5.89e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CB—breast cancer	6.87e-07	5.87e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—breast cancer	6.85e-07	5.86e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—breast cancer	6.8e-07	5.82e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT1—breast cancer	6.59e-07	5.63e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HRAS—breast cancer	6.55e-07	5.6e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—breast cancer	6.27e-07	5.36e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTEN—breast cancer	5.93e-07	5.07e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT1—breast cancer	5.79e-07	4.95e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CA—breast cancer	5.37e-07	4.59e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CA—breast cancer	4.94e-07	4.22e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CA—breast cancer	4.9e-07	4.19e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AKT1—breast cancer	4.39e-07	3.75e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CA—breast cancer	4.19e-07	3.58e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AKT1—breast cancer	4.04e-07	3.45e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AKT1—breast cancer	4e-07	3.42e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AKT1—breast cancer	3.42e-07	2.92e-06	CbGpPWpGaD
